Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06875284 · ClinicalTrials.gov registry record · NA

Evaluating Cross-Cutting Prevention at the U.S. Air Force Academy

A NA study of Sexual Assault and Alcohol Misuse, sponsored by RTI International.

Completed
Registry status
NA
Development phase
2,041
Enrollment target
1
Study location

NCT06875284: Completed NA study of Sexual Assault and Alcohol Misuse, sponsored by RTI International.

NCT06875284 is a NA study of Sexual Assault and Alcohol Misuse that has completed, run by RTI International. The registered enrollment target is 2,041 participants, above the 580-participant average among 12 other Sexual Assault trials with a reported enrollment target (252% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06875284, a NA study of Sexual Assault and Alcohol Misuse, has completed, sponsored by RTI International.

COMPLETED
Registry status
NA
Development phase
2,041 participants
Enrollment target
1
Study location

Study Summary

Sexual assault and alcohol misuse are interrelated, persist at high rates in military populations, and carry negative consequences for military units and personnel. Combining tailored efforts to prevent sexual assault and alcohol misuse is critical for developing a more effective Force. This study will test the cross-cutting immediate and long-term outcomes of two programs, the Sexual Communication and Consent (SCC) sexual assault prevention program and the eCHECKUP TO GO alcohol misuse prevention program, delivered separately and in combination, with Cadets at the United States Air Force Academy. Anonymous Cadet self-report data will be collected before training (pre-test), immediately after training (post-test), 3 months after training (Fall semester follow-up), and 9 months after training (Spring semester follow-up).

Primary Outcome

Participants self-report whether they experienced any type of unwanted sexual contact between Basic Cadet Training and the Spring semester follow-up using a modified version of the Sexual Experiences Survey.

Interventions

  • BEHAVIORAL Sexual Communication and Consent (SCC)
  • BEHAVIORAL Alcohol eCHECKUP TO GO (eCHECKUP TO GO)
  • BEHAVIORAL Training as usual (TAU)

Study Locations (1)

Colorado

  • United States Air Force Academy - Air Force Academy

Trial Details

FieldValue
Enrollment Target 2,041 participants
Start Date 2022-06-27
Est. Completion 2024-05-01
Phase NA
RTI International

45 total trials

What the finished NCT06875284 record still lists

NCT06875284 is an interventional study that assigns participants to a tested intervention. Its 2,041 participants enrollment target places it among the larger protocols in the corpus, above the 580-participant average among 12 other Sexual Assault trials with a reported enrollment target (252% higher).

The record links to 2 conditions, with Sexual Assault appearing as the primary indexed condition, and to 3 interventions - of which Sexual Communication and Consent (SCC) is the first listed.

NCT06875284 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT06875284 about?

NCT06875284 is a clinical study titled "Evaluating Cross-Cutting Prevention at the U.S. Air Force Academy". Sexual assault and alcohol misuse are interrelated, persist at high rates in military populations, and carry negative consequences for military units and personnel. Combining tailored efforts to prevent sexual assault and alcohol misuse is critical for developing a more effective Force. This study w...

What is the current status of trial NCT06875284?

This trial is currently completed. It is a NA study. The enrollment target is 2,041 participants. The study started on 2022-06-27. Estimated completion is 2024-05-01.

What conditions does trial NCT06875284 study?

This clinical trial studies the following conditions: Sexual Assault, Alcohol Misuse.

What interventions are being tested in trial NCT06875284?

The interventions under investigation include: Sexual Communication and Consent (SCC) (BEHAVIORAL), Alcohol eCHECKUP TO GO (eCHECKUP TO GO) (BEHAVIORAL), Training as usual (TAU) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06875284?

This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06875284 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sexual Assault

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06875284's enrollment target sits among peer trials

2,041 2nd of 12 the highest of 12 other Sexual Assault trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sexual Assault trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05138718 · 2,041 participants

    FDG an Myocardial Infarction: The PIAF Trial

  • NCT06825897 · 2,039 participants · NA

    Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe

  • NCT06833476 · 2,044 participants

    TTVR STRONG Under Coverage With Evidence Development (CED) Study

  • NCT05688982 · 2,049 participants · NA

    MOLAR: Mapping Oral Health and Local Area Resources

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06875284, the US trial registry maintained by the National Library of Medicine. NCT06875284 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.